New research from a team of genome scientists and DNA damage response experts breaks new ground in understanding the function of a protein currently limited in clinical trials for cancer treatments.
Biologists have used machine learning, a type of AI, to identify 'synthetic extreme' DNA sequences with specifically designed functions in gene activation. They tested 50 million DNA sequences and ...
“[...] the biological mechanisms linking aging and osteoarthritis prevalence remain largely unknown.” “In this study, we use irradiation as an acute model of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results